1 Department of Pharmacology, The Squibb Institute for Medical Research, New Brunswick, New Jersey 08903
2 >Department of Pharmacology, The Squibb Institute for Medical Research, New Brunswick, New Jersey 08903
Effects of close intra-arterial injections of angiotensins I and II on changes in renal blood flow and renal vascular resistance were studied in dogs anesthetized with pentobarbital sodium. In the first series of experiments, angiotensin I (0.375 µg) or angiotensin II (0.13 µg) decreased renal blood flow and pressures in a small renal cortical vein and the renal vein. Although renal vascular resistance was markedly increased by angiotensins I or II, these increases did not appear to involve renal venous segments. Responses to angiotensin I occurred when the injected agonist was not allowed to reach the systemic circulation, and were virtually abolished during infusion of SQ 20475, a synthetic pentapeptide (Pyr-Lys-Try-Ala-Pro) that inhibits enzymatic conversion of angiotensin I to angiotensin II. In the second series of experiments, renal vascular responses to intra-arterial injections of angiotensin I (0.375-3.75 µg) and angiotensin II (0.13-1.00 µg) were studied. Responses to angiotensin I, but not those to angiotensin II, were significantly attenuated by SQ 20475. The results suggest that similar renal vascular segments respond to angiotensins I and II. Responses to angiotensin I are probably due to its intrarenal conversion to angiotensin II. Such conversion appears to occur to the extent of about 4%.
Submitted on March 24, 1971
Accepted on August 13, 1971
This article has been cited by other articles:
![]() |
J. C. Q. Velez, K. J. Ryan, C. E. Harbeson, A. M. Bland, M. N. Budisavljevic, J. M. Arthur, W. R. Fitzgibbon, J. R. Raymond, and M. G. Janech Angiotensin I Is Largely Converted to Angiotensin (1-7) and Angiotensin (2-10) by Isolated Rat Glomeruli Hypertension, May 1, 2009; 53(5): 790 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bauer, H. Berthold, F. Schaefer, H. Ehmke, and N. Parekh Quantification of conversion and degradation of circulating angiotensin in rats Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1999; 277(2): R412 - R418. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Hollenberg, N. D. L. Fisher, and D. A. Price Pathways for Angiotensin II Generation in Intact Human Tissue : Evidence From Comparative Pharmacological Interruption of the Renin System Hypertension, September 1, 1998; 32(3): 387 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Hollenberg and N. D. L. Fisher Renal Circulation and Blockade of the Renin-Angiotensin System : Is Angiotensin-Converting Enzyme Inhibition the Last Word? Hypertension, October 1, 1995; 26(4): 602 - 609. [Abstract] [Full Text] |
||||
![]() |
W. Flamenbaum Pathophysiology of Acute Renal Failure Arch Intern Med, June 1, 1973; 131(6): 911 - 928. [Abstract] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1971 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |